wir freuen uns Ihnen das aktuellste Update zur Covid-19 Impfung für Hochrisikopatienten mitteilen zu dürfen:
In dieser Woche sollen in Wien rund 105.500 Corona-Impftermine freigegeben werden. (ab 12.04.2021)
Hochrisikopatienten, Personen über 65 Jahre, Kontaktpersonen von Schwangeren und Personen mit Behinderungen können ihren Termin dann buchen. Weiterlesen
Die Anmeldung erfolgt, wie gewohnt, über das Portal impfservice.wien
Falls Sie PatientInn bei uns in der Ordination sind und ein Risikoattest benötigen, kontaktieren Sie uns bitte unter diabetesFIT.org@gmail.com
Das Attest kann per Mail und/oder per Post an Sie verschickt werden.
Alle vereinbarten Termine bleiben aufrecht. Neue Terminvereinbarungen vorläufig nur per text message (sms) unter 06604919749 oder per e-mail an diabetesFIT.org@gmail.com.
Willkommen bei
Competent Patient Leadership
Welcome in Metabolic Competence Centre!
Our Mission: Competent Patient Leadership
Research Group
Functional Rehabilitation and Group Education, Vienna
We are the ISO-9001 certified research group, headed by Professor Kinga Howorka, MD; non-profit organisation providing medical research, structured individual and group education for self-treatment in diabetes and related diseases.
Our main focus is diabetes mellitus with special interest in Type 1 diabetes, pregnancy in diabetes and/or hypoglycemia unawareness. Further on, components of metabolic syndrome such as hypertension, dyslipidemia and obesity are of particular interest, as well. Non-invasive medical aesthetics treatments, body contouring with radiofrequency and injection lipolysis, thread lifting and PRP (Platelets-Rich-Plasma / "Vampire-Lift") are our further fields of expertise within the concept of comprehensive antiaging.
Our offices are located in center of Vienna, Austria and we closely cooperate with Medical University of Vienna, Center of Medical Physics and Biomedical Engineering, as well as with other medical university research and/or pharmaceuticals research groups.
Functional Insulin Treatment means that insulin is used functionally to imitate insulin production in a healthy pancreas. It is used functionally by separate replacement of:
Basal
- insulin necessary to sustain the body while fasting, and
Prandial
- or meal-related insulin, and
Correction
insulin, necessary to lower blood glucose levels to the preferred target.
This system allows to adjust the insulin supply you need with 4 to 6 daily insulin injections or with an insulin pump. The insulin is personalized to individual requirements based on several daily blood glucose self-measurements (or better on continuous glucose sensor), appetite (requirements for food) or fasting needs. Delayed-acting insulin (e.g., Lantus®, Tresiba® or Toujeo® (long-acting insulin analogs) injections or a pump is needed to cover basal or fasting insulin needs. Eating, or correcting high blood glucose levels requires a rapid-acting insulin.
NEWS
In Austria, new long-acting insulin analogs Tresiba® (NovoNordisk) and Toujeo®, U-300 insulin glargine (sanofi-aventis) are now available ("yellow box" in respect to reimbursement).
